Related Experiment Video
Updated: Jul 2, 2025

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
Published on: February 16, 2024
The Vaginal Microbiome Changes During Various Fertility Treatments
M M van den Tweel1,2, E H A van den Munckhof3, M van der Zanden2
1Department of Obstetrics and Gynaecology, Leiden University Medical Center, Leiden, The Netherlands.
Hormonal treatments during fertility procedures like in vitro fertilization (IVF) can negatively impact the vaginal microbiome, decreasing beneficial Lactobacilli. This may affect pregnancy outcomes, suggesting potential benefits from adjusting treatment timing or strategies.
Area of Science:
- Reproductive Endocrinology and Infertility
- Microbiome Research
- Gynecologic Health
Background:
- Bacterial vaginosis (BV) is linked to reduced fecundity and adverse pregnancy outcomes, particularly in women undergoing assisted reproductive technologies.
- The influence of hormonal stimulation protocols used in fertility treatments on the vaginal microbiome composition remains incompletely understood.
Purpose of the Study:
- To investigate the impact of hormonal treatments on the vaginal microbiome during fertility treatments, focusing on changes in Lactobacilli abundance.
- To explore the relationship between vaginal microbiome alterations and pregnancy outcomes in individuals undergoing intra uterine insemination (IUI) and in vitro fertilization (IVF).
Main Methods:
- Prospective cohort study involving 53 couples undergoing fertility treatments (IUI, IVF, ICSI) between July 2019 and August 2022.
- Vaginal samples collected at multiple time points during treatment cycles.
- Quantitative PCR (qPCR) for BV detection and 16S rRNA gene sequencing for microbiome analysis.
Main Results:
- A significant decrease in Lactobacilli percentage was observed during fertility treatments, indicating a shift in the vaginal microbiome.
- 24% of participants tested positive for BV via qPCR, with 9 individuals transitioning from BV-negative to BV-positive status during treatment.
- No significant difference in the Shannon diversity index was found between groups or over time, though a trend towards higher diversity in those who developed BV was noted.
Conclusions:
- Hormonal treatments in fertility settings can lead to vaginal dysbiosis, characterized by reduced Lactobacilli, potentially impacting treatment success.
- Monitoring vaginal microbiome status during fertility treatments may be beneficial.
- Consideration of treatment timing, lifestyle adjustments, or a 'freeze-all' strategy could mitigate negative effects of vaginal microbiome deterioration.
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Disorders of the Female Reproductive System
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Oogenesis

